Keywords: دیپپتیدیل پپتیداز 4; Dipeptidyl peptidase 4; Glucagon like peptide 1; Glucose dependent insulinotropic polypeptide; Incretins; Type 2 diabetes; Dyslipidemia; Soluble DPP4;
مقالات ISI دیپپتیدیل پپتیداز 4 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: دیپپتیدیل پپتیداز 4; Cardiovascular diesease; Dipeptidyl peptidase 4 inhibitor; Atherosclerosis; Heart failure; Myocardial infarction; AMI; acute myocardial infarction; BNP; Brain natriuretic peptide; CD26; cluster of differentiation 26; CHD; coronary heart disease; CKD; chro
Keywords: دیپپتیدیل پپتیداز 4; ACKR; atypical chemokine receptor; ADAM; a disintegrin and metalloprotease; [Ca2+]i; intracellular calcium concentration; CTAP-III; connective tissue-activating peptide III; DPP4; dipeptidyl peptidase 4; ERK; extracellular signal-regulated kinase; GAG; gl
Keywords: دیپپتیدیل پپتیداز 4; ADA; American Diabetes Association; BMI; body mass index; CGM; continuous glucose monitoring; DPP-4; dipeptidyl peptidase 4; GLP-1; glucagon-like peptide 1; mTORC1/2; mammalian target of rapamycin complex 1/2; OGTT; oral glucose tolerance test; PTDM; post
Keywords: دیپپتیدیل پپتیداز 4; AGEs; Advanced glycation end products; ADMA; Asymmetric dimethylarginine; cAMP; Cyclic adenosine monophosphate; DPP-4; Dipeptidyl peptidase 4; GLP-1; Glucagon-like peptide 1; GLP-1R; Glucagon-like peptide 1 receptor; HMGB-1; High mobility group box 1 prot
Keywords: دیپپتیدیل پپتیداز 4; Asthma; Control; Biologics; Eosinophilic asthma; Severe asthma; Uncontrolled asthma; DDP-4; dipeptidyl peptidase 4; Feno; fraction of exhaled nitric oxide; GINA; Global Initiative for Asthma; ICS; inhaled corticosteroid; LABA; long-acting beta2 agonist; S
Keywords: دیپپتیدیل پپتیداز 4; Biologics; asthma; urticaria; nasal polyps; mAbs; cytokines; IgE; CAPS; Cryopyrin-associated periodic syndrome; DPP-4; Dipeptidyl peptidase 4; FDA; US Food and Drug Administration; Feno; Fraction of exhaled nitric oxide; IVIG; Intravenous immunoglobulin;
Keywords: دیپپتیدیل پپتیداز 4; Enteroendocrine Cells; Obesity; Gastrointestinal Peptides; Apo A-IV; apolipoprotein A-IV; BA; bile acids; CB1R; cannabinoid receptor 1 receptor CB1R; CCK; cholecystokinin; CCK-1R; CCK-1 receptor; CNS; central nervous system; DAG; des-acyl ghrelin; DIO; di
Keywords: دیپپتیدیل پپتیداز 4; DPP-4; dipeptidyl peptidase 4; GLP-1; glucagon-like peptide-1; NC; bombesin/neuromedin C; GLP-1; Lymph; DPP-4; Portal vein; Lamina propria; Neuromedin C;
Keywords: دیپپتیدیل پپتیداز 4; Crossover studies; Nitrites; Nitrates; Blood glucose; Hyperglycemia; Blood glucose; Insulin; ANOVA; analysis of variance; BMI; body mass index; DPP-4; dipeptidyl peptidase 4; HbA1c; glycated hemoglobin; HOMA-IR; homeostatic model of insulin resistance; iA
Keywords: دیپپتیدیل پپتیداز 4; Dipeptidyl peptidase 4; DPP-4 inhibitors; GLP-1 receptor agonists; Glucagon-like peptide 1; Incretin effect; Incretin mimetics; Pharmacotherapy;
Keywords: دیپپتیدیل پپتیداز 4; ACU; azocasein unit; ALP1; alkaline protease 1; CCD; central composite design; DH; degree of hydrolysis; DPP4; dipeptidyl peptidase 4; DPP5; dipeptidyl peptidase 5; DTT; dithiothreitol; h; concentration of free amino groups; htot; maximum concentration of
Keywords: دیپپتیدیل پپتیداز 4; ADAM; a disintegrin and metalloprotease; bref A; brefeldin A; DPP4; Dipeptidyl peptidase 4; sDPP4; soluble dipeptidyl peptidase 4; MMP; matrix metalloprotease; SMC; human vascular smooth muscle cell; TACE; tumor necrosis factor α converting enzyme; CD26/
Keywords: دیپپتیدیل پپتیداز 4; ACE-I; angiotensin-converting enzyme inhibitor; ARB; angiotension receptor blocker; BMI; body mass index; Cr; creatinine; CVD; cardiovascular disease; DPP-4; dipeptidyl peptidase 4; GAD-65; glutamic acid decarboxylase; GLP-1; glucagon-like peptide 1; GFR;
Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus
Keywords: دیپپتیدیل پپتیداز 4; MERS-CoV; Middle East respiratory syndrome coronavirus; DPP4; Dipeptidyl peptidase 4; RBD; Receptor binding domain; ORF; Open reading frame; Ad5/MERS; Adenovirus 5 expressing MERS-CoV spike protein; MERS-CoV; Vaccine; Adenovirus 5; Th1; Th2; Heterologous
Constitutive DPP4 activity, inflammation, and microvascular reactivity in subjects with excess body weight and without diabetes
Keywords: دیپپتیدیل پپتیداز 4; ADA; American Diabetes Association; AUC; area uder the curve; BMI; body mass index; CD26; cluster of differentiation 26; DPP4; dipeptidyl peptidase 4; EDTA; ethylenediamine tetraacetic acid; FPG; fasting plasma glucose; GIP; glucose-dependent insulinotrop
Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profiling
Keywords: دیپپتیدیل پپتیداز 4; Dipeptidyl peptidase 4; Peptidase inhibitor; Porphyromonas gingivalis; Biofilm; Dipeptidyl peptidase 9; DPP; dipeptidyl peptidase; hDPP4; human dipeptidyl peptidase 4; MAD; Multiwavelength Anomalous Dispersion; pgDPP4; Porphyromonas gingivalis dipeptidyl
Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes
Keywords: دیپپتیدیل پپتیداز 4; Chemokine; Posttranslational modification; Protease; Dipeptidyl peptidase 4; Lymphocyte migration;
Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease
Keywords: دیپپتیدیل پپتیداز 4; CD36; DPP4; GLP-1; Insulin resistance; NAFLD; PPARγ; Ad; adenovirus; Akt; Akt serine-threonine protein kinase; ALT; alanine aminotransferase; ApoB; apolipoprotein B; AST; aspartate aminotransferase; BAT; brown adipose tissue; CD36; fatty acid transloca
Use of hydrogel scaffolds to develop an in vitro 3D culture model of human intestinal epithelium
Keywords: دیپپتیدیل پپتیداز 4; Caco-2 cells; HT29-MTX cells; Alginate; l-pNIPAM; l-pNIPAM-co-DMAc; ISEMF; Intestinal subepithelial myofibroblast; PLGA; Poly Lactic-co-Glycolic Acid; NIPAM; N-isopropylacrylamide; AIBN; 2-2â²-azobisisobutyronitrile; LCST; lower critical solution tempera
Altered circulating concentrations of active glucagon-like peptide (GLP-1) and dipeptidyl peptidase 4 (DPP4) in obese subjects and their association with insulin resistance
Keywords: دیپپتیدیل پپتیداز 4; Obesity; Insulin resistance; Dipeptidyl peptidase 4; sDPP4; GLP-1;
Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide
Keywords: دیپپتیدیل پپتیداز 4; Hepatocyte nuclear factor 1b; Nonalcoholic fatty liver disease; Lipogenensis; Endoplasmic reticulum stress; Dipeptidyl peptidase 4; Nicotinamide adenine dinucleotide phosphate oxidase 1; Superoxide;
Mechanisms of the amplifying pathway of insulin secretion in the β cell
Keywords: دیپپتیدیل پپتیداز 4; ABCC8; ATP binding cassette subfamily C member 8; ADCY5; adenylyl cyclase type 5; AICAR; 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside; DPP-IV; dipeptidyl peptidase 4; G6PD; glucose-6-phosphate dehydrogenase; GDH; glutamate dehydrogenase; GIP; gast
Prognostic Significance of Serum CD26 Concentration in Patients with Esophageal Squamous Cell Carcinoma
Keywords: دیپپتیدیل پپتیداز 4; Esophageal squamous cell carcinoma; Dipeptidyl peptidase 4; CD26; Prognosis; Serum
Liraglutide restores angiogenesis in palmitate-impaired human endothelial cells through PI3K/Akt-Foxo1-GTPCH1 pathway
Keywords: دیپپتیدیل پپتیداز 4; DAHP; 2,4-diamino-6-hydroxypyrimidine; DPP-4; dipeptidyl peptidase 4; eNOS; endothelial nitric oxide synthase; Foxo1; forkhead box O1; GLP-1; glucagon-like peptide-1; GTPCH1; guanosine 5â²-triphosphate cyclohydrolase 1; HUVECs; human umbilical vein endot
Cardiac atrial appendage stem cells promote angiogenesis in vitro and in vivo
Keywords: دیپپتیدیل پپتیداز 4; ALDH; aldehyde dehydrogenase; ANG; angiogenin; Ang-1; angiopoietin-1; CAM; chorioallantoic membrane; CASC; cardiac atrial appendage stem cell; CM; conditioned medium; CSC; cardiac stem cell; DAPI; 4â²,6-diamidino-2-phenylindole; DPPIV; dipeptidyl peptida
Dipeptidyl peptidase 4 - An important digestive peptidase in Tenebrio molitor larvae
Keywords: دیپپتیدیل پپتیداز 4; Dipeptidyl peptidase 4; DPP 4; Insect digestive peptidases; Proline specific serine peptidase; Yellow mealworm; Tenebrio molitor;
Identifying neuropeptide Y (NPY) as the main stress-related substrate of dipeptidyl peptidase 4 (DPP4) in blood circulation
Keywords: دیپپتیدیل پپتیداز 4; Dipeptidyl peptidase 4; Neuropeptide Y; MALDI-TOF-MS; Major depressive disorders; Neuropeptides; Blood circulation;
Metabolism of peptide YY 3-36 in Göttingen mini-pig and rhesus monkey
Keywords: دیپپتیدیل پپتیداز 4; AUC; area under the curve; DPP-IV; dipeptidyl peptidase 4; EIC; extracted ion chromatogram; LC-MS; liquid chromatography mass spectrometry; m/z; mass-to-charge ratio; NPY; neuropeptide Y; ppm; parts per million; PYY3-36; peptide YY 3-36; PP; pancrea
Boning up on DPP4, DPP4 substrates, and DPP4-adipokine interactions: Logical reasoning and known facts about bone related effects of DPP4 inhibitors
Keywords: دیپپتیدیل پپتیداز 4; ALP; alkaline phosphatase,; APN(R); adiponectin (receptor); BMD; bone mineral density; Coll1; collagen type 1; CXCR4; C-X-C chemokine receptor 4; DPP4; dipeptidyl peptidase 4 (CD26: cluster of differentiation 26); GLP-1/2; glucagon-like peptide 1/2; GIP;
Transcriptomic analysis of Rongchang pig brains and livers
Keywords: دیپپتیدیل پپتیداز 4; RNA-seq; RNA sequencing; DEGs; differentially expressed genes; NMS; neuromedin S; MSH; melanocyte-stimulating hormone; ECLP; extracorporeal liver perfusion; SAGE; serial analysis of gene expression; IGFBPs; insulin-like growth factor binding proteins; qRT
Inhibition of DPP4/CD26 and dmPGE2 treatment enhances engraftment of mouse bone marrow hematopoietic stem cells
Keywords: دیپپتیدیل پپتیداز 4; Hematopoietic stem cells; Engraftment; Bone marrow; Cord blood; Prostaglandin E2; Dipeptidyl peptidase 4;
Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs
Keywords: دیپپتیدیل پپتیداز 4; Fibroblast; Dipeptidyl peptidase; Protease substrates; Protease activity; Liver disease; Fibrosis; Biomarker; ALD; alcoholic liver disease; AMC; amino-4-methylcoumarin; DPP4; dipeptidyl peptidase 4; DMSO; dimethyl sulfoxide; EDTA; ethylene diamine tetra a
Low DPP4 expression and activity in multiple sclerosis
Keywords: دیپپتیدیل پپتیداز 4; Dipeptidyl peptidase 4; CD26; Multiple sclerosis; Biomarker; Clinical activity;
Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?
Keywords: دیپپتیدیل پپتیداز 4; Aβ; amyloid beta; AD; Alzheimer's disease; Akt; protein kinase B; α-syn; α-synuclein; BAD; Bcl-2 antagonist of death; BBB; blood brain barrier; Bcl-2; B-cell lymphoma 2; Bcl-XL; B-cell lymphoma extra large; Bim; Bcl-2 interacting mediator of death; cAM
Cardiovascular Effects of Incretins in Diabetes
Keywords: دیپپتیدیل پپتیداز 4; cardiac function; dipeptidyl peptidase 4; glucagon-like peptide 1; incretin; stromal cell-derived factor 1fonctionnement cardiaque; dipeptidyl peptidase 4; GLP-1 (glucagon-like peptide-1); incrétine; facteur dérivé des cellules stromales de type 1
Dipeptidyl peptidase-4 expression is reduced in Crohn's disease
Keywords: دیپپتیدیل پپتیداز 4; ANOVA; analysis of variance; CD; Crohn's disease; CDAI; Crohn's disease activity index; CRP; C-reactive protein; DP4; dipeptidyl peptidase 4; DSS; dextran sodium sulphate; EEC; enteroendocrine cell; GAPDH; glyceraldehyde 3 phosphate dehydrogenase; GIP; gl
Clinical diagnostic utility of adenosine deaminase, interferon-γ, interferon-γ–induced protein of 10 kDa, and dipeptidyl peptidase 4 levels in tuberculous pleural effusions
Keywords: دیپپتیدیل پپتیداز 4; Adenosine deaminase; Dipeptidyl peptidase 4; Interferon-γ; Interferon-γ–induced protein of 10 kDa; Tuberculous pleural effusion
NPY suppressed development of experimental autoimmune encephalomyelitis in Dark Agouti rats by disrupting costimulatory molecule interactions
Keywords: دیپپتیدیل پپتیداز 4; EAE; Dipeptidyl peptidase 4; Neuropeptide Y; Rat;
Isolation of mouse pancreatic alpha, beta, duct and acinar populations with cell surface markers
Keywords: دیپپتیدیل پپتیداز 4; CK19; cytokeratin 19; CFTR; cystic fibrosis transmembrane receptor; MafA; musculoaponeurotic fibrosarcoma oncogene homolog A; GP2; glycoprotein 2; Pdx1; pancreatic and duodenal homeobox factor 1; HNF4α; hepatocyte nuclear factor 4 alpha; TTR; transthyret
Neuropeptide Y modulates functions of inflammatory cells in the rat: Distinct role for Y1, Y2 and Y5 receptors
Keywords: دیپپتیدیل پپتیداز 4; NPY; neuropeptide Y; LP-NPY; [Leu31,Pro34]-NPY; hAAib-NPY; [hPP1-17, Ala31, Aib32]-NPY; LPS; lipopolysaccharide; DP4; dipeptidyl peptidase 4; NBT; nitro blue tetrazolium chloride; PBS; phosphate buffered saline; MEM; minimal essential medium without pheno
Verification of a biomarker discovery approach for detection of Down syndrome in amniotic fluid via multiplex selected reaction monitoring (SRM) assay
Keywords: دیپپتیدیل پپتیداز 4; AD; Alzheimer's disease; AF; amniotic fluid; CEL; bile salt-activated lipase; CN; chromosomally normal; CPA1; carboxypeptidase 1; DPP4; dipeptidyl peptidase 4; DS; Down syndrome; iSRM; intelligent SRM; MMP2; matrix metalloproteinase-2; MUC13; mucin-13; SR
Research ArticleGlucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase
Keywords: دیپپتیدیل پپتیداز 4; GLP-1; glucagon like peptide-1; DPP4; dipeptidyl peptidase 4; DPP4; DPP4-deficient rats; AMPK; cAMP activated kinase; Ad-DN-AMPK; AMPK adenovirus-dominant negative; GLP-1R; GLP-1 receptor; PEPCK; phosphoenol pyruvate carboxykinase; G6P; glucose-6-phosphat
Strategies for Optimizing Glycemic Control and Cardiovascular Prognosis in Patients With Type 2 Diabetes Mellitus
Keywords: دیپپتیدیل پپتیداز 4; ACCORD; Action to Control Cardiovascular Risk in Diabetes; ADVANCE; Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation; CAD; coronary artery disease; CI; confidence interval; CV; cardiovascular; DM; diab
Synthesis and biological evaluation of azobicyclo[3.3.0] octane derivatives as dipeptidyl peptidase 4 inhibitors for the treatment of type 2 diabetes
Keywords: دیپپتیدیل پپتیداز 4; Azobicyclo[3.3.0]octane derivatives; Dipeptidyl peptidase 4; Oral glucose tolerance test; Type 2 diabetes mellitus;
Discovery of new chemotype dipeptidyl peptidase IV inhibitors having (R)-3-amino-3-methyl piperidine as a pharmacophore
Keywords: دیپپتیدیل پپتیداز 4; Dipeptidyl peptidase 4; DPP-4; Dipeptidyl peptidase 4 inhibitors; DPP-4 inhibitors; 3-Amino-piperidine; (R)-3-Amino-3-methyl piperidine
Synthesis, SAR, and atropisomerism of imidazolopyrimidine DPP4 inhibitors
Keywords: دیپپتیدیل پپتیداز 4; Dipeptidyl peptidase 4; DPP4; Atropisomerism
Synthesis and biological evaluation of bicyclo[3.3.0] octane derivatives as dipeptidyl peptidase 4 inhibitors for the treatment of type 2 diabetes
Keywords: دیپپتیدیل پپتیداز 4; Bicyclo[3.3.0]octane derivatives; Dipeptidyl peptidase 4; Inhibitors; Oral glucose tolerance tests; Type 2 diabetes;
A Physiologic and Pharmacological Basis for Implementation of Incretin Hormones in the Treatment of Type 2 Diabetes Mellitus
Keywords: دیپپتیدیل پپتیداز 4; ADA; American Diabetes Association; AE; adverse event; CI; confidence interval; DM; diabetes mellitus; DPP-4; dipeptidyl peptidase 4; EASD; European Association for the Study of Diabetes; GIP; glucose-dependent insulinotropic polypeptide; GLP-1; glucagon-
Defining and Achieving Treatment Success in Patients With Type 2 Diabetes Mellitus
Keywords: دیپپتیدیل پپتیداز 4; ACCORD; Action to Control Cardiovascular Risk in Diabetes; ACT NOW; ACTos NOW for the Prevention of Diabetes; ADVANCE; Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release and Controlled Evaluation; BP; blood pressure; CVD; car